Antibiotic prophylaxis in acute childhood leukemia: What is known so far?

INTRODUCTION: The treatment of acute lymphoblastic leukemia (ALL) has evolved in recent decades, reaching an overall survival rate close to 90%. Currently, approximately 4% of patients with ALL die from secondary complications of chemotherapy. Among these complications, the most frequent is febrile...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufrayer, Mauro Cesar, Monteiro, Yasmine Massaro Carneiro, Carlesse, Fabianne Altruda de Moraes Costa, Motta, Fabrizio, Daudt, Liane Esteves, Michalowski, Mariana Bohns
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627853/
https://www.ncbi.nlm.nih.gov/pubmed/36522273
http://dx.doi.org/10.1016/j.htct.2022.09.1279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627853/
https://www.ncbi.nlm.nih.gov/pubmed/36522273
http://dx.doi.org/10.1016/j.htct.2022.09.1279

Ejemplares similares